PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Aelis Farma SA (AELIS.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0014007ZB4
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap€76.32M
EPS (TTM)-€0.39
Total Revenue (TTM)€8.65M
Gross Profit (TTM)€6.66M
EBITDA (TTM)-€7.23M
Year Range€5.45 - €13.75
Target Price€21.30

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aelis Farma SA

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Aelis Farma SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%AprilMayJuneJulyAugustSeptember
-58.06%
5.69%
AELIS.PA (Aelis Farma SA)
Benchmark (^GSPC)

S&P 500

Returns By Period

Aelis Farma SA had a return of -57.25% year-to-date (YTD) and -59.42% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-57.25%15.21%
1 month-52.54%2.83%
6 months-58.36%6.19%
1 year-59.42%22.46%
5 years (annualized)N/A12.84%
10 years (annualized)N/A10.74%

Monthly Returns

The table below presents the monthly returns of AELIS.PA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20243.05%-1.48%-2.63%0.39%1.54%-3.03%-7.03%-4.20%-57.25%
20232.95%1.87%-0.56%-0.50%-0.36%-0.36%-0.00%-1.43%-1.82%0.37%-1.11%-2.24%-3.25%
20225.40%3.16%-1.02%-9.59%-8.32%-2.49%-5.29%-0.77%-11.94%4.74%42.53%7.46%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AELIS.PA is 3, indicating that it is in the bottom 3% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of AELIS.PA is 33
AELIS.PA (Aelis Farma SA)
The Sharpe Ratio Rank of AELIS.PA is 33Sharpe Ratio Rank
The Sortino Ratio Rank of AELIS.PA is 99Sortino Ratio Rank
The Omega Ratio Rank of AELIS.PA is 00Omega Ratio Rank
The Calmar Ratio Rank of AELIS.PA is 11Calmar Ratio Rank
The Martin Ratio Rank of AELIS.PA is 00Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Aelis Farma SA (AELIS.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AELIS.PA
Sharpe ratio
The chart of Sharpe ratio for AELIS.PA, currently valued at -1.10, compared to the broader market-4.00-2.000.002.00-1.10
Sortino ratio
The chart of Sortino ratio for AELIS.PA, currently valued at -1.27, compared to the broader market-6.00-4.00-2.000.002.004.00-1.27
Omega ratio
The chart of Omega ratio for AELIS.PA, currently valued at 0.42, compared to the broader market0.501.001.502.000.42
Calmar ratio
The chart of Calmar ratio for AELIS.PA, currently valued at -0.96, compared to the broader market0.001.002.003.004.005.00-0.96
Martin ratio
The chart of Martin ratio for AELIS.PA, currently valued at -5.50, compared to the broader market-10.000.0010.0020.00-5.50
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.83, compared to the broader market-4.00-2.000.002.001.83
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.49, compared to the broader market-6.00-4.00-2.000.002.004.002.49
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.502.001.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.64, compared to the broader market0.001.002.003.004.005.001.64
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.72, compared to the broader market-10.000.0010.0020.008.72

Sharpe Ratio

The current Aelis Farma SA Sharpe ratio is -1.10. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Aelis Farma SA with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.003.00AprilMayJuneJulyAugustSeptember
-1.10
1.56
AELIS.PA (Aelis Farma SA)
Benchmark (^GSPC)

Dividends

Dividend History


Aelis Farma SA doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AprilMayJuneJulyAugustSeptember
-60.78%
-4.14%
AELIS.PA (Aelis Farma SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aelis Farma SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aelis Farma SA was 61.83%, occurring on Sep 4, 2024. The portfolio has not yet recovered.

The current Aelis Farma SA drawdown is 60.78%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-61.83%Feb 20, 2023394Sep 4, 2024
-37.95%Mar 18, 2022171Nov 15, 202258Feb 6, 2023229
-5.94%Feb 28, 20224Mar 3, 20229Mar 16, 202213
-4.76%Feb 21, 20221Feb 21, 20221Feb 22, 20222
-3.69%Feb 24, 20221Feb 24, 20221Feb 25, 20222

Volatility

Volatility Chart

The current Aelis Farma SA volatility is 74.52%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%AprilMayJuneJulyAugustSeptember
74.52%
4.36%
AELIS.PA (Aelis Farma SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aelis Farma SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Aelis Farma SA.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items